Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Lymphoma | Case report

Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report

Authors: Maria Bonou, Chris J. Kapelios, Athanasios Marinakos, Stamatis Adamopoulos, Panagiotis Diamantopoulos, Periklis G. Foukas, Loukas Kaklamanis, Penelope Korkolopoulou, John Barbetseas, Nora-Athina Viniou

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Primary cardiac lymphomas (PCL) represent extremely rare cardiac tumors which are accompanied by poor prognosis, unless they are timely diagnosed and treated.

Case presentation

Herein we present a 28-year-old, immunocompetent man who presented to our hospital due to progressively worsening symptoms and signs of superior vena cava syndrome. Multi-modality imaging demonstrated a large intracardiac tumor, which was proven, by biopsy, to be a PCL. The patient received targeted chemotherapy which led to total remission of his disease, with no relapse over a 15-month follow-up period.

Conclusions

Although PCLs are rare, they should always be kept in mind in the differential diagnosis of cardiac tumors. Timely diagnosis of PCLs and appropriate chemotherapy, alone or in combination with radiotherapy, seems to provide the best results.
Literature
1.
go back to reference Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77:107.CrossRef Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77:107.CrossRef
2.
go back to reference Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027.PubMed Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027.PubMed
3.
go back to reference Johri A, Baetz T, Isotalo PA, Nolan RL, et al. Primary cardiac diffuse large B cell lymphoma presenting with superior vena cava syndrome. Can J Cardiol. 2009;25:e210–2.CrossRef Johri A, Baetz T, Isotalo PA, Nolan RL, et al. Primary cardiac diffuse large B cell lymphoma presenting with superior vena cava syndrome. Can J Cardiol. 2009;25:e210–2.CrossRef
4.
go back to reference Coiffier B, Lepage E, Brière J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–42.CrossRef Coiffier B, Lepage E, Brière J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–42.CrossRef
5.
go back to reference Shah K, Shemisa KA. "Low and slow" approach to successful medical treatment of primary cardiac lymphoma. Cardiovasc Diagn Ther. 2014;4(3):270–3.PubMedPubMedCentral Shah K, Shemisa KA. "Low and slow" approach to successful medical treatment of primary cardiac lymphoma. Cardiovasc Diagn Ther. 2014;4(3):270–3.PubMedPubMedCentral
6.
go back to reference Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.CrossRef Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.CrossRef
7.
go back to reference Camacho AF, Hernández FH, Pérez JT. Primary cardiac lymphoma: diagnosis by transjugular biopsy. Rev Esp Cardiol. 2003;56:1141–4.CrossRef Camacho AF, Hernández FH, Pérez JT. Primary cardiac lymphoma: diagnosis by transjugular biopsy. Rev Esp Cardiol. 2003;56:1141–4.CrossRef
8.
go back to reference Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol. 2011;149(3):358–63.CrossRef Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol. 2011;149(3):358–63.CrossRef
9.
go back to reference Montanaro C, Loiacono F, Fragasso G, et al. Primary cardiac lymphoma in an immunocompetent 71-year-old man. Tex Heart Inst J. 2015;42(6):561–4.CrossRef Montanaro C, Loiacono F, Fragasso G, et al. Primary cardiac lymphoma in an immunocompetent 71-year-old man. Tex Heart Inst J. 2015;42(6):561–4.CrossRef
10.
go back to reference Ceresoli GL, Ferreri AJM, Bucci E, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer. 1997;80:1497–506.CrossRef Ceresoli GL, Ferreri AJM, Bucci E, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer. 1997;80:1497–506.CrossRef
11.
go back to reference Castelli JB, Alexandre L, Futuro G, et al. Primary cardiac lymphoma detected by 18F-FDG PET scan: a case report. J Nucl Cardiol. 2011;18(5):974–7.CrossRef Castelli JB, Alexandre L, Futuro G, et al. Primary cardiac lymphoma detected by 18F-FDG PET scan: a case report. J Nucl Cardiol. 2011;18(5):974–7.CrossRef
12.
go back to reference Nijjar PS, Masri SC, Tamene A, et al. Benefits and limitations of multimodality imaging in the diagnosis of a primary cardiac lymphoma. Tex Heart Inst J. 2014;41(6):657–9.CrossRef Nijjar PS, Masri SC, Tamene A, et al. Benefits and limitations of multimodality imaging in the diagnosis of a primary cardiac lymphoma. Tex Heart Inst J. 2014;41(6):657–9.CrossRef
13.
go back to reference Chim CS, Chan AC, Kyong YL, et al. Primary cardiac lymphoma. Am J Hematol. 1997;54:79–83.CrossRef Chim CS, Chan AC, Kyong YL, et al. Primary cardiac lymphoma. Am J Hematol. 1997;54:79–83.CrossRef
14.
go back to reference Gowda RM, Khan IA. Clinical perspectives of primary cardiac lymphoma. Angiology. 2003;54(5):599–604.CrossRef Gowda RM, Khan IA. Clinical perspectives of primary cardiac lymphoma. Angiology. 2003;54(5):599–604.CrossRef
15.
go back to reference Annibali O, Nenna A, Barbato R, Chello M, Sedati P, Bianchi A, Deda G, Avvisati G. Primary cardiac MYC/BCL6 double hit non-Hodgkin lymphoma. J Cardiol Cases. 2017;17(3):103–6.CrossRef Annibali O, Nenna A, Barbato R, Chello M, Sedati P, Bianchi A, Deda G, Avvisati G. Primary cardiac MYC/BCL6 double hit non-Hodgkin lymphoma. J Cardiol Cases. 2017;17(3):103–6.CrossRef
16.
go back to reference Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 2010;116(12):2040–5.CrossRef Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 2010;116(12):2040–5.CrossRef
Metadata
Title
Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report
Authors
Maria Bonou
Chris J. Kapelios
Athanasios Marinakos
Stamatis Adamopoulos
Panagiotis Diamantopoulos
Periklis G. Foukas
Loukas Kaklamanis
Penelope Korkolopoulou
John Barbetseas
Nora-Athina Viniou
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5405-y

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine